The Direct and Indirect Effects of Serofendic Acid on Neuroprotection
: Serofendic acid is a novel neuroprotective factor isolated from fetal calf serum. To elucidate the mechanisms how serofendic acid exerts neuroprotection, we examined its effects on glutamate‐induced excito‐toxicity in mouse cortical neurons. The effects of serofendic acid on inflammatory cytokine...
Saved in:
Published in | Annals of the New York Academy of Sciences Vol. 1086; no. 1; pp. 91 - 103 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Malden, USA
Blackwell Publishing Inc
01.11.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | : Serofendic acid is a novel neuroprotective factor isolated from fetal calf serum. To elucidate the mechanisms how serofendic acid exerts neuroprotection, we examined its effects on glutamate‐induced excito‐toxicity in mouse cortical neurons. The effects of serofendic acid on inflammatory cytokine and neurotrophin production by glial cells were also examined to evaluate the indirect neuroprotection. Serofendic acid significantly and dose dependently increased survival of mouse cortical neurons after 10 μM N‐methyl‐D‐asparate (NMDA) exposure. However, it did not affect production of inflammatory cytokines and neurotrophins by microglia as assessed by reverse transciption polymerase chain reaction (RT‐PCR) for mRNA expression and ELISA for protein levels, though it suppressed tumor necrosis factor (TNF)‐α production by astrocytes. Thus, serofendic acid works directly on neurons to protect against glutamate toxicity. Suppression of TNF‐α production by astoryctes may also synergistically exert neuroprotective functions of serofendic acid. Serofendic acid may be of use for the future therapeutic strategy against ischemic and degenerative neurological disorders. |
---|---|
Bibliography: | istex:586C88732712E271F11C336790B291FB73688BF3 ArticleID:NYAS9 ark:/67375/WNG-VMT70J6M-7 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0077-8923 1749-6632 1930-6547 |
DOI: | 10.1196/annals.1377.009 |